• Investinq
  • Posts
  • šŸ‘‘ Microsoft Dethrones Apple

šŸ‘‘ Microsoft Dethrones Apple

+ Health Insurers Just Got a $25 Billion Gift

Good afternoon! Colossal Biosciences just unveiled its boldest project yet: recreating the long-extinct dire wolf using CRISPR-edited gray wolf DNA. The startup, which boasts a $10B+ valuation and George R.R. Martin as an adviser, introduced three engineered pupsā€”Remus, Romulus, and Khaleesiā€”on a secret preserve in the U.S. The pups share 99.5% of their DNA with modern gray wolves, but 20 genes were edited to give them that signature dire wolf look.

Colossal claims this is the first time an extinct species has been ā€œbrought back,ā€ though some scientists disagree. Critics argue the animals are more cosplay than comebackā€”genetically tweaked gray wolves, not full-blown de-extincted beasts. The question now: is this Jurassic Park for real, or just a very expensive science experiment with great marketing?

MARKETS

*Stock data as of market close*

  • Tuesday opened with stocks surging on hopes that the White House would soften its tariff stance. All 30 Dow stocks kicked off in the green after President Trump teased ā€œgreat callsā€ with South Korea and hinted China might soon follow. At one point, the Dow was up nearly 1,500 points, and investors were cautiously eyeing a trade breakthrough.

  • But those calls never came, and by mid-afternoon, reality bit back. The Dow flipped over 1,700 points from high to low, closing down 320 points for its fourth straight loss. The S&P 500 dropped 1.6%, slipping below 5,000 for the first time in a year, while the Nasdaq slid 2.2%. A looming 104% cumulative tariff on Chinese goodsā€”set to hit just after midnightā€”sent markets tumbling into the close.

STOCKS
Winners & Losers

Whatā€™s up šŸ“ˆ

  • Health insurers soared after the government announced a $25 billion boost to Medicare Advantage plans in 2026. Humana jumped 10.69%, UnitedHealth Group rose 5.41%, and CVS Health gained 5.92%. ($HUM, $UNH, $CVS)

  • Coal stocks rallied on reports President Trump will declare coal a national security asset. Peabody Energy rose 9.21%, while Core Natural Resources gained 4.55%. ($BTU, $CNRC)

  • Lockheed Martin added 2.91% as defense names rallied after President Trump pledged a $1 trillion defense budget. ($LMT)

Whatā€™s down šŸ“‰

  • Tilray Brands fell 21.23% on a miss in Q3 earnings and narrowed guidance. ($TLRY)

  • Apple dropped 4.98%, extending its losing streak despite hopes it could offset China tariffs with iPhone production in India. ($AAPL)

  • Janover plummeted 12.94% after revealing a new Solana-focused crypto strategy and rebrand plan. ($JNVR)

  • Greenbrier the railcar manufacturer declined 11.42% after slashing full-year revenue guidance. ($GBX)

  • Levi Strauss slid 8% after an early pop on solid earnings faded as tariff worries returned. ($LEVI)

  • Harley-Davidson dropped 8.60% after CEO Jochen Zeitz announced plans to retire later this year. ($HOG)

  • Infineon Technologies dipped 4.87% after acquiring Marvellā€™s auto ethernet business. ($IFNNY)

STOCK
Apple Hands Crown Back To Microsoft

A trillion here, a trillion there, and suddenly Microsoft is back on top.

After a brutal four-day slide that shaved 23% off Appleā€™s stock, Microsoft has officially reclaimed the title of the worldā€™s most valuable company. Appleā€™s market cap now sits at $2.59 trillion, just behind Microsoftā€™s $2.64 trillion. Thatā€™s a far cry from the near-$4 trillion valuation Apple boasted just a few months ago.

The culprit? A full-on tariff shock. Trumpā€™s aggressive new trade measuresā€”including a headline-grabbing 104% tariff on Chinese importsā€”have hit Cupertino especially hard. With most of Appleā€™s supply chain rooted in China, investors are pricing in an iPhone thatā€™s both more expensive to make and harder to sell.

UBS estimates the iPhone 16 Pro Max could cost Americans up to $350 more. Thatā€™s not exactly the kind of upgrade pitch consumers love to hear.

A Bitter Pill with a Short-Term Sugar Coating

Strangely enough, the fear of higher prices has spurred a mini-buying spree. Shoppers are rushing to grab current iPhones before the tariff-driven price tags kick in. But donā€™t mistake that for a comebackā€”analysts say the long-term picture still looks grim unless Apple finds a workaround.

The Case for a Bounce?

Not everyoneā€™s panicking. Bank of America called Appleā€™s plunge a ā€œparticularly enhanced buying opportunity,ā€ arguing the stockā€™s drop pushed it below a key valuation threshold (a 25x forward P/E). Theyā€™ve slapped a $250 price target on it, banking on a rebound powered by production shifts to India or supplier cost cuts.

But that kind of optimism comes with asterisks. The current definition of ā€œcheapā€ in this market is still historically expensive. And the sample size of Apple bouncing from these levels? Letā€™s just say itā€™s not statistically bulletproof.

Still, in a market where giants are tumbling, Microsoftā€™s more diversified business model and software-heavy revenue mix may offer a bit more insulationā€”at least for now.

NEWS
Market Movements

HEALTHCARE
Health Insurers Just Got a $25 Billion Gift


The Trump administration gave health insurance stocks a reason to smileā€”and rally like itā€™s 2020.

In a surprise move, Medicare Advantage plans are getting a 5.06% payment boost for 2026, more than double the 2.23% increase proposed by the Biden administration just a few months ago. Thatā€™s $25 billion in new revenue for the industryā€”and Wall Street is eating it up.

The Market Reaction Was Immediate

Shares of Humana surged 10.69%, CVS Health popped nearly 5.92%, and UnitedHealth Group gained 5.41% on the news. Even the broader health care ETF (XLV) inched up as investors recalibrated what had been a bleak year for insurers.

The reversal signals strong White House backing for Medicare Advantageā€”the private version of Medicare that now covers over 30 million seniors. Trumpā€™s pick to lead the Medicare agency? None other than Dr. Mehmet Oz, who has both supported the program and criticized its worst billing abuses. (Yes, that Dr. Oz.)

Whatā€™s Behind the Hike?

The Centers for Medicare and Medicaid Services said rising medical costs and newer data justified the larger-than-expected bump. The rate hike also comes after the administration scrapped a Biden-era plan to cover obesity drugsā€”another potential cost driver.

Even with the payment lift, the administration is still pushing forward with a crackdown on so-called "upcoding," where insurers boost reimbursements by logging extra diagnoses. But Wall Street shrugged that off for now.

The Bottom Line: Insurers just dodged a revenue headwind and turned it into a tailwind. Whether it lasts may depend on how serious Oz & Co. get about reform. But for now, investors are all smilesā€”and a tad bit richer.

Calendar
On The Horizon

Tomorrow

Nothing major on the economic data front tomorrow, but one earnings report could get extra attention. A company squarely in the crosshairs of the new tariff wave is set to post resultsā€”and Wall Street will be watching closely to see how itā€™s handling the pressure.

Before Market Open:

  • Delta Air Lines may have one of the steadiest flight paths in the industry, but even it isnā€™t immune to turbulence. As the largest U.S. carrier, its earnings tomorrow will offer a high-altitude view of how airlines are navigating a tougher environment marked by weaker consumer demand, shrinking corporate travel budgets, and macro uncertainty. With tariffs looming and fuel costs volatile, investors are counting on Delta to map out a clear flight plan for the rest of the year. Solid financials give it an edge, but this earnings call will be more about direction than dollars. Wall Street is forecasting $0.80 in EPS on $13.39 billion in revenue ($DAL).

NEWS
The Daily Rundown

RESOURCES
The Federal Reserve Resource

Join our small yet growing subreddit šŸš€: https://www.reddit.com/r/investinq/

Wall Street Reads šŸ’Ž (Best Books):

Check out our latest issues šŸŽÆ: https://investinq.beehiiv.com